Gary Kupfer, MD

Professor of Pediatrics (Hematology / Oncology) and of Pathology; Section Chief, Pediatric Hematology/Oncology; Clinical Program Leader, Pediatric Hematology & Oncology Program, Smilow Cancer Hospital; Disease Aligned Research Team Leader, Pediatric Hematology & Oncology Program, Yale Cancer Center

Departments & Organizations

Pediatrics: Kupfer Lab | Pediatric Hematology & Oncology: Pediatric Hemophilia Program

Pathology: Experimental Pathology Graduate Program

Cancer Genetics

Molecular Virology: Virology Laboratories

Stem Cell Center, Yale

Yale Cancer Center: Pediatric Hematology & Oncology Program | Radiobiology & Radiotherapy

Yale Combined Program in the Biological and Biomedical Sciences (BBS): Molecular Cell Biology, Genetics and Development | Molecular Medicine, Pharmacology, and Physiology

Yale Cooperative Center of Excellence in Hematology (YCCEH)

Yale Medicine

Office of Cooperative Research


The Kupfer laboratory is working on HTLV I Tax protein, which has a unique kinase activation activity. They are harnessing this activity in order to chemosensitize p53 mutant tumor cells, thereby serving as an adjunct to enhance cancer therapy.<_o3a_p>

Education & Training

MD Johns Hopkins University School of Medicine (1989)
BS University of Florida (1983)
Post-doctoral Fellow Dana-Farber Cancer Institute, Boston, MA
Fellow Children's Hospital, Boston, MA
Resident Children's Hospital of Philadelphia, Philadelphia, PA
Research Associate John Hopkins School of Medicine Baltimore, MD
Board Certification AB of Pediatrics, Pediatric Hematology-Oncology (1996, recertified: 2011)

Honors & Recognition

  • Commonwealth Health Research Board grant awardee (2005)

  • NIH K02 career development award (2002)

  • Concern Foundation Cancer Research Award (2000)

Edit this profile